☆ 4.6 Article

Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Peritoneal Carcinomatosis: Additional Information Helps to Optimize Patient Selection before Surgery

CANCERS (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Incidence and mortality trends in gastric cancer in the United States, 1992-2019

Mengding Chen et al.

Summary: Our study aimed to estimate the epidemiological trends of gastric cancer in the United States from 1992 to 2019. We found that the incidence and mortality rates of gastric cancer have declined in the past decades, but the proportion of distant gastric cancer cases has unexpectedly increased. The progression of primary and tertiary preventive measures is the main reason for the reduction in the disease burden of gastric cancer. However, secondary preventive measures for gastric cancer still need to be strengthened.

INTERNATIONAL JOURNAL OF CANCER (2023)

Add to Collection

Article Oncology

Prognostic Impact of Hepatic Steatosis Evaluated by CT on Immunotherapy for Gastric Cancer: Associations with Sarcopenia, Systemic Inflammation, and Hormones

Koichi Hayano et al.

Summary: The study aimed to evaluate the prognostic impact of hepatic steatosis in ICI therapy for gastric cancer. The results showed a significant association between hepatic steatosis and fatty liver and inflammatory markers, as well as a significant correlation with the prognosis indicators DSS and PFS. The study suggests that hepatic steatosis may be a reliable biomarker for ICI therapy in gastric cancer.

ONCOLOGY (2023)

Add to Collection

Article Oncology

Neutrophil-to-lymphocyte ratio before each chemotherapy line predicts clinical outcomes in patients with unresectable gastric cancer

Hiroaki Tanioka et al.

Summary: The neutrophil-to-lymphocyte ratio (NLR) is a prognostic biomarker for patients with gastric cancer. This study evaluated the clinical impact of NLR in patients with gastric cancer treated with different chemotherapies. The results showed that patients with NLR > 3.00 had worse overall survival at each treatment stage, and NLR could predict treatment outcomes in patients with unresectable gastric cancer, including those treated with nivolumab.

ONCOLOGY LETTERS (2023)

Add to Collection

Article Oncology

Novel prognostic indicator combining inflammatory indicators and tumor markers for gastric cancer

Liang Yu et al.

Summary: This study found that the neutrophil-to-lymphocyte ratio (NLR) and CA19-9 were independent prognostic factors for gastric cancer patients. The NLR-CA19-9 score (NCS), which is a combination of the two factors, can provide more accurate predictions of the prognosis of gastric cancer patients, and its predictive value is significantly better than that of traditional inflammatory indicators or tumor markers.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2023)

Add to Collection

Article Surgery

Neutrophil-to-lymphocyte-ratio-based perioperative prognosis prediction model on early mortality after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

Hao-Chien Hung et al.

Summary: This study developed a predictive model for early mortality and found that incomplete cytoreductive surgery, major postoperative complications, higher pre-operative neutrophil-to-lymphocyte ratio (NLR), and dynamic NLR changes were significant predictors of early mortality. The "triple P" model showed strong determination in predicting outcomes.

ASIAN JOURNAL OF SURGERY (2022)

Add to Collection

Review Oncology

Impact of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis: A Systematic Review and Meta-analysis

Mariana Martins et al.

Summary: This systematic review suggests that CRS + HIPEC treatment can significantly improve the survival of patients with GCPC compared to CRS alone, reduce the risk of peritoneal recurrence, and is not associated with a significant increase in complications.

ANNALS OF SURGICAL ONCOLOGY (2022)

Add to Collection

Article Oncology

Prognostic impact of hepatic steatosis evaluated by CT on immunotherapy for gastric cancer; associations with sarcopenia, systemic inflammation, and hormones

Koichi Hayano et al.

Summary: This study aimed to evaluate the prognostic impact of hepatic steatosis in ICIs therapy for gastric cancer. The results showed that hepatic steatosis was associated with prognostic indicators, particularly with sarcopenia and the elevation of inflammatory markers.

ONCOLOGY (2022)

Add to Collection

Article Oncology

Response Prediction in Immune Checkpoint Inhibitor Immunotherapy for Advanced Hepatocellular Carcinoma

Hao-Chien Hung et al.

Summary: In this study, the effects of immunotherapy in treating advanced hepatocellular carcinoma were examined, with NLR <= 2.5 and PG-SGA score < 4 identified as biomarkers for predicting tumor response to immune checkpoint inhibitor (ICI) treatment.

CANCERS (2021)

Add to Collection

Article Oncology

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP)

Israel Manzanedo et al.

ANNALS OF SURGICAL ONCOLOGY (2019)

Add to Collection

Article Multidisciplinary Sciences

Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study

Takayuki Shiroyama et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Article Surgery

Surgical treatment of peritoneal metastases of gastric cancer

A. Brandl et al.

CHIRURG (2018)

Add to Collection

Article Oncology

Current status and future prospects of clinical trials on CRS plus HIPEC for gastric cancer peritoneal metastases

Zhong-He Ji et al.

INTERNATIONAL JOURNAL OF HYPERTHERMIA (2017)

Add to Collection

Review Oncology

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: Progress toward a new standard of care

Paul H. Sugarbaker

CANCER TREATMENT REVIEWS (2016)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Proposed radiological criteria for pre-operative determination of resectability in peritoneal-based malignancies

Grace Hwei Ching Tan et al.

JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2016)

Add to Collection

Article Oncology

Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis

F. Coccolini et al.

EJSO (2015)

Add to Collection

Article Oncology

Peritoneal carcinomatosis of gastric origin: A population-based study on incidence, survival and risk factors

Irene Thomassen et al.

INTERNATIONAL JOURNAL OF CANCER (2014)

Add to Collection

Article Surgery

Rates and Patterns of Recurrence after Curative Intent Resection for Gastric Cancer: A United States Multi-Institutional Analysis

Gaya Spolverato et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2014)

Add to Collection

Article Gastroenterology & Hepatology

Treatment options in patients with metastatic gastric cancer: Current status and future perspectives

Ahmet Bilici

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Add to Collection

Article Oncology

Initial Clinical Experience with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Signet-Ring Cell Gastric Cancer with Peritoneal Metastases

Ingmar Koenigsrainer et al.

JOURNAL OF GASTRIC CANCER (2014)

Add to Collection

Article Oncology

Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Advanced Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy

Manabu Kaneko et al.

ONCOLOGY (2012)

Add to Collection

Article Oncology

Comparison of Two Inflammation-Based Prognostic Scores in Patients with Unresectable Advanced Gastric Cancer

Jae-Heon Jeong et al.

ONCOLOGY (2012)

Add to Collection

Article Oncology

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial

Xiao-Jun Yang et al.

ANNALS OF SURGICAL ONCOLOGY (2011)

Add to Collection

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

CELL (2011)

Add to Collection

Article Oncology

Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy

Olivier Glehen et al.

ANNALS OF SURGICAL ONCOLOGY (2010)

Add to Collection

Review Oncology

Surgical treatment for peritoneal carcinomatosis from gastric cancer

Y. Yonemura et al.

EJSO (2010)

Add to Collection

Article Oncology

Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer

Yutaka Yonemura et al.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2010)

Add to Collection

Article Oncology

Evaluation of Preoperative Computed Tomography in Estimating Peritoneal Cancer Index in Colorectal Peritoneal Carcinomatosis

Ju-Li Koh et al.

ANNALS OF SURGICAL ONCOLOGY (2009)

Add to Collection

Article Oncology

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

Wasaburo Koizumi et al.

LANCET ONCOLOGY (2008)

Add to Collection

Review Biochemistry & Molecular Biology

The hallmarks of cancer

D Hanahan et al.

CELL (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.